Harvard School of Medicine/Massachusetts General Hospital (MGH) — Boston, Massachusetts

Harvard School of Medicine/Massachusetts General Hospital (MGH) is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Harvard School of Medicine/Massachusetts General Hospital (MGH) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Bladder Cancer, Urinary Bladder Neoplasm, Urologic Neoplasms.

Sponsors: Cedars-Sinai Medical Center.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Harvard School of Medicine/Massachusetts General Hospital (MGH)?

Harvard School of Medicine/Massachusetts General Hospital (MGH) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Harvard School of Medicine/Massachusetts General Hospital (MGH) conducted?

Harvard School of Medicine/Massachusetts General Hospital (MGH) has 1 clinical trials on record, with 1 currently active. Their work covers Bladder Cancer, Urinary Bladder Neoplasm, Urologic Neoplasms.

Is Harvard School of Medicine/Massachusetts General Hospital (MGH) accredited by Crixeo Health?

Harvard School of Medicine/Massachusetts General Hospital (MGH) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Harvard School of Medicine/Massachusetts General Hospital (MGH)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.